Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Hepatitis

Free Subscription 24.11.2025 1 AIDS 2 Am J Gastroenterol 1 Arch Virol 1 BMC Cancer 2 Clin Infect Dis 1 Gastroenterology 1 Hepatology 4 J Hepatol 1 J Immunol 1 J Infect Dis 4 J Med Virol 2 J Viral Hepat 1 Pediatr Infect Dis J 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. HAGE K, Carson J, Hosseini-Hooshyar S, Sacks-Davis R, et al
   Behavioural trajectories following DAA treatment for HCV among people with HIV: findings from an international consortium of prospective cohort studies.
   AIDS. 2025 Nov 17. doi: 10.1097/QAD.0000000000004408.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

2. GRONBAEK L, Sandahl TD, Jepsen P
   The risk of psychiatric disorders in patients with autoimmune hepatitis: a nationwide registry-based follow-up study.
   Am J Gastroenterol. 2025 Nov 19. doi: 10.14309/ajg.0000000000003857.
   PubMed         Abstract available
   
   
3. SWAIN LA, Godley J, Wang M, Brahmania M, et al
   Temporal and demographic trends in alcohol-related-cirrhosis, alcohol-related hepatitis, and non-alcohol-related cirrhosis hospitalizations from 2012-2023: A population-based study in Alberta, Canada.
   Am J Gastroenterol. 2025 Nov 14. doi: 10.14309/ajg.0000000000003835.
   PubMed         Abstract available
   
   

   
   Arch Virol

4. NAKANO T, Okano H, Uraki S, Ono T, et al
   Hepatitis E virus subtype 3f infections: rare but increasingly identified in Japan.
   Arch Virol. 2025;170:252.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. MA Y, Lou C, Liang J, Guo C, et al
   Characteristics of extracellular vesicle-derived lncRNAs during the progression of HBV-related hepatocellular carcinoma.
   BMC Cancer. 2025;25:1768.
   PubMed         Abstract available
   
   

   
   Clin Infect Dis

6. OLCOTT F, Oddie PD, Barlow MJ, Mamarelis A, et al
   Hepatitis B reactivation following switch away from tenofovir-containing anti-retroviral therapy in people living with HIV: A case series and lessons for practice.
   Clin Infect Dis. 2025 Nov 19:ciaf634. doi: 10.1093.
   PubMed         Abstract available
   
   
7. VAN SANTEN DK, Chalouni M, Berenguer J, Jarrin I, et al
   Risk of hepatocellular carcinoma after direct-acting antiviral treatment for hepatitis C virus infection in people with HIV.
   Clin Infect Dis. 2025 Nov 19:ciaf635. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Gastroenterology

8. LOK AS, Ward JW, Chang MH, Cohen C, et al
   Hepatitis B Vaccination: A remarkable success story that must continue.
   Gastroenterology. 2025 Nov 13:S0016-5085(25)06482.
   PubMed        
   
   

   
   Hepatology

9. STRAIN R, Edmans M, Montalvo Zurbia-Flores G, Frumento N, et al
   The development of a pan-genotypic T cell vaccine against hepatitis C virus using heterologous prime-boost strategies.
   Hepatology. 2025 Nov 14. doi: 10.1097/HEP.0000000000001599.
   PubMed         Abstract available
   
   

   
   J Hepatol

10. SANDMANN L
    The identification of interleukin-27 as one key player in restoring virus-specific T-cell dysfunction in chronic hepatitis B virus infection.
    J Hepatol. 2025 Nov 19:S0168-8278(25)02604-2. doi: 10.1016/j.jhep.2025.
    PubMed        
    
    
11. WANG J, Fan T, Zhu C, Wu C, et al
    Prevalence and Antiviral Treatment Rate in Chronic Hepatitis B Patients with a Family History of HCC.
    J Hepatol. 2025 Nov 14:S0168-8278(25)02621-2. doi: 10.1016/j.jhep.2025.
    PubMed        
    
    
12. LE BERT N, Koffas A, Kumar R, Facchetti F, et al
    Rapid whole-blood immune profiling reveals heterogeneous HBV-specific T cell response patterns independent of clinical disease phases.
    J Hepatol. 2025;83:1292-1304.
    PubMed         Abstract available
    
    
13. CHAN LL, Chan AWH, Yip TCF, Wong GLH, et al
    Attenuation of the second peak of bimodal recurrence of HBV-related HCC after curative treatment in the antiviral era.
    J Hepatol. 2025;83:1328-1337.
    PubMed         Abstract available
    
    

    
    J Immunol

14. MOSTERT TP, Kessler AL, Luijten RJ, Doelman W, et al
    Bioorthogonal click chemistry to visualize an immunogenic HLA-A2-restricted hepatitis B virus epitope in human monocyte-derived dendritic cells.
    J Immunol. 2025 Nov 20:vkaf312. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Infect Dis

15. HUME SJ, Visvanathan K, Cheng K, Jackson K, et al
    Anti-HBs immune complex levels: A novel marker of hepatitis flare following nucleos(t)ide analogue withdrawal in HBeAg-negative chronic hepatitis B.
    J Infect Dis. 2025 Nov 14:jiaf569. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

16. FAZLI P, Bakhtiari S, Jalilian FA, Teimoori A, et al
    Clinical and Immunological Impact of Occult Hepatitis B Virus Infection Among HIV-Infected Patients With and Without HCV Co-Infection in Iran: A Cross-Sectional Analysis.
    J Med Virol. 2025;97:e70715.
    PubMed         Abstract available
    
    
17. HUANG R, Ji F, Jiang Y, Li S, et al
    Sofosbuvir/Velpatasvir/Voxilaprevir Versus Sofosbuvir/Velpatasvir Plus Ribavirin in Patients With Hepatitis C Virus Genotype 3b and Compensated Cirrhosis: A Multicentre Randomized Controlled Trial.
    J Med Virol. 2025;97:e70709.
    PubMed         Abstract available
    
    
18. BOUCETTA Y, Boschi C, Peroni E, Jean R, et al
    Co-Infection With Hepatitis E Virus and SARS-CoV-2 in a Lymphoma Patient.
    J Med Virol. 2025;97:e70706.
    PubMed         Abstract available
    
    
19. ABDEL-SAMIEE M, Aburaia G, Abdelsameea E, Fathy S, et al
    Solute Carrier Gene Polymorphism (SLC29A1) in Relation to Treatment Outcome and Hematological Changes in Chronic Hepatitis C Patients Treated With Direct Acting Antivirals Plus Ribavirin.
    J Med Virol. 2025;97:e70692.
    PubMed         Abstract available
    
    

    
    J Viral Hepat

20. DRYSDALE M, Gillespie IA, Christensen D, Davies J, et al
    Characterisation of People Living With Chronic Hepatitis B Virus Infection in England and Stratification by HBsAg Levels: A Cross-Sectional Study.
    J Viral Hepat. 2025;32:e70101.
    PubMed         Abstract available
    
    
21. MARCELLIN F, di Beo V, Sogni P, Ramier C, et al
    Bridging the Gap: How Distance to Hospitals Limits HCV Treatment Initiation in France.
    J Viral Hepat. 2025;32:e70102.
    PubMed        
    
    

    
    Pediatr Infect Dis J

22. PAWLOWSKA M, Zarebska-Michaluk D, Dobrowolska K, Moppert J, et al
    Pangenotypic Glecaprevir/Pibrentasvir Therapy for Chronic Hepatitis C in Children.
    Pediatr Infect Dis J. 2025 Nov 20. doi: 10.1097/INF.0000000000005069.
    PubMed         Abstract available
    
    

    
    PLoS One

23. IBRAHIM N, Jones S, Rich K, Alvarez L, et al
    Evaluation of a "one-stop shop" for integrated harm reduction and primary care for people who inject drugs.
    PLoS One. 2025;20:e0337528.
    PubMed         Abstract available
    
    
24. KINAI E, Ishikura M, Miyashita R, Yamaguchi T, et al
    Serology change-based clinical interpretation of indeterminate serostatus post-hepatitis B virus infection in people living with HIV.
    PLoS One. 2025;20:e0336924.
    PubMed         Abstract available
    
    
25. KHUMALO N, Mankahla A, Korsman S, Gumedze F, et al
    Scalp haircuts, keloids and blood-borne virus transmission risk in South Africa-The SHAKA study.
    PLoS One. 2025;20:e0336213.
    PubMed         Abstract available
    
    
26. SPERLE I, Lunchenkov N, Stepanovich-Falke A, Nurmatov ZS, et al
    Barriers and facilitators to HIV and viral hepatitis testing in primary healthcare settings in the Kyrgyz Republic: A mixed-methods study using the COM-B Framework.
    PLoS One. 2025;20:e0336257.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.